IP Library Patent Application 18352846
Patent Application
App. No. 18/352,846

SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/352,846
Abstract

The present technology is directed generally to electrical stimulation and associated systems and methods. For example, the present technology provides stimulation schedules/regimens that are expected to reduce the amount of power required for paresthesia-free stimulation, while maintaining the benefits of paresthesia-free stimulation. This is accomplished by reducing the dose of paresthesia-free neurostimulation provided to a patient over time. The dose can be reduced without a corresponding reduction, or significant reduction, in effectiveness.

Claims (49)

1 . A method of treating pain in a patient, comprising:

delivering a first paresthesia-free electrical signal to the patient's spinal cord region via an implanted signal delivery device for a first stimulation period and according to a first stimulation schedule in which the first paresthesia-free electrical signal is delivered for at least 12 hours per day, wherein the first paresthesia-free electrical signal reduces the patient's pain; and

after the first stimulation period, delivering a second paresthesia-free electrical signal to the patient's spinal cord region via the implanted signal delivery device for a second stimulation period and according to a second stimulation schedule in which the second paresthesia-free electrical signal is delivered for less than 6 hours per day, wherein the second paresthesia-free electrical signal at least partially maintains the reduction in the patient's pain achieved during the first stimulation period.

2 . The method of claim 1 wherein delivering the first paresthesia-free electrical signal according to the first stimulation schedule includes continuously delivering the first paresthesia-free electrical signal during the first stimulation period.

3 . The method of claim 2 wherein continuously delivering the first paresthesia-free electrical signal includes delivering the first paresthesia-free electrical signal for 24 hours at a pulse dose rate of less than 100%.

4 . The method of claim 1 wherein delivering the second paresthesia-free electrical signal according to the second stimulation schedule includes delivering the second paresthesia-free electrical signal during only a single stimulation session per day.

5 . The method of claim 4 wherein the single stimulation session has a duration of between about 10 minutes and about 4 hours.

6 . The method of claim 4 wherein the single stimulation session has a duration of between about 10 minutes and about 2 hours.

7 . The method of claim 4 wherein the single stimulation session has a duration of between about 10 minutes and about 1 hour.

8 . The method of claim 4 wherein the single stimulation session has a duration of between about 15 minutes and about 45 minutes.

9 . The method of claim 4 wherein the single stimulation session has a duration of about 1 hour.

10 . The method of claim 4 wherein the single stimulation session has a duration of about 45 minutes.

11 . The method of claim 4 wherein the single stimulation session has a duration of about 30 minutes.

12 . The method of claim 4 wherein the single stimulation session has a duration of about 15 minutes.

13 . The method of claim 1 wherein delivering the second paresthesia-free electrical signal according to the second stimulation schedule includes delivering the second paresthesia-free electrical signal during two or more stimulation sessions per day.

14 . The method of claim 13 wherein individual stimulation sessions of the two or more stimulation sessions have a duration of between about 10 minutes and about 2 hours.

15 . The method of claim 13 wherein individual stimulation sessions of the two or more stimulation sessions have a duration of between about 15 minutes and about 45 minutes.

16 . The method of claim 13 wherein the two or more stimulation sessions per day are separated by at least 4 hours.

17 . The method of claim 13 wherein delivering the second paresthesia-free electrical signal according to the second stimulation schedule includes delivering the second paresthesia-free electrical signal during only two stimulation sessions per day.

18 . The method of claim 13 wherein delivering the second paresthesia-free electrical signal according to the second stimulation schedule includes delivering the second paresthesia-free electrical signal during only three stimulation sessions per day.

19 . The method of claim 1 wherein delivering the second paresthesia-free electrical signal according to the second stimulation schedule includes delivering the second paresthesia-free electrical signal during only one, two, three, four, five, or six stimulation sessions per week.

20 . The method of claim 19 wherein the second paresthesia-free electrical signal is delivered only during four or fewer stimulation sessions per week.

21 . The method of claim 19 wherein the second paresthesia-free electrical signal is delivered during a single stimulation session per week.

22 . The method of claim 1 wherein the first stimulation period has a predetermined duration.

23 . The method of claim 22 wherein the predetermined duration is between about 1 month and about 1 year.

24 . The method of claim 1 wherein the second stimulation period has an indefinite duration.

25 . The method of claim 1 wherein the first paresthesia-free electrical signal has the same frequency as the second paresthesia-free electrical signal.

26 . The method of claim 1 wherein the first paresthesia-free electrical signal has a different frequency than the second paresthesia-free electrical signal.

27 . The method of claim 1 wherein at least one of the first paresthesia-free electrical signal or the second paresthesia-free electrical signal has a frequency in a frequency range of from about 1.2 kHz to about 100 kHz.

28 . The method of claim 1 wherein at least one of the first paresthesia-free electrical signal or the second paresthesia-free electrical signal has a frequency in a frequency range of from about 1 Hz to about 1000 Hz.

29 . The method of claim 1 wherein at least one of the first paresthesia-free electrical signal or the second paresthesia-free electrical signal has a pulse width in a pulse width range of from about 5 milliseconds to about 2 seconds.

30 . The method of claim 1 wherein delivering the first paresthesia-free electrical signal and delivering the second paresthesia-free electrical signal includes using an implanted signal generator with a primary cell battery to generate the first paresthesia-free electrical signal and the second paresthesia-free electrical signal.

31 . The method of claim 1 wherein delivering the first paresthesia-free electrical signal and delivering the second paresthesia-free electrical signal includes using an external signal generator to generate and deliver the first paresthesia-free electrical signal and the second paresthesia-free electrical signal.

32 . The method of claim 1 , further comprising, after the second stimulation period, delivering a third paresthesia-free electrical signal to the patient's spinal cord region via the implanted signal delivery device for a third stimulation period and according to a third stimulation schedule in which the third paresthesia-free electrical signal is delivered for less than 2 hours per day, and where the third paresthesia-free electrical signal at least partially maintains the reduction in the patient's pain achieved during the first stimulation period and the second stimulation period.

33 . A method of treating a patient, comprising:

delivering a first paresthesia-free electrical signal to a target neural population of the patient via an implanted signal delivery device for a first stimulation period and according to a first stimulation schedule in which the first paresthesia-free electrical signal is delivered for at least 12 hours per day, wherein the first paresthesia-free electrical signal alleviates one or more patient symptoms; and

after the first stimulation period, delivering a second paresthesia-free electrical signal to the target neural population via the implanted signal delivery device for a second stimulation period and according to a second stimulation schedule in which the second paresthesia-free electrical signal is delivered for less than 6 hours per day, wherein the second paresthesia-free electrical signal at least partially maintains the alleviation of the one or more patient symptoms achieved during the first stimulation period.

34 - 61 . (canceled)

62 . A method of treating a patient, the method comprising:

programming a signal generator to:

deliver a first paresthesia-free electrical signal to a target neural population in the patient via an implanted signal delivery device for a first stimulation period and according to a first stimulation schedule in which the first paresthesia-free electrical signal is delivered for at least 12 hours per day, wherein the first paresthesia-free electrical signal at least partially alleviates one or more patient symptoms; and

after the first stimulation period, automatically deliver a second paresthesia-free electrical signal to the target neural population via the implanted signal delivery device for a second stimulation period and according to a second stimulation schedule in which the second paresthesia-free electrical signal is delivered for less than 6 hours per day, wherein the second paresthesia-free electrical signal at least partially maintains the alleviation of the one or more patient symptoms achieved during the first stimulation period.

63 - 71 . (canceled)

72 . A patient treatment system, comprising:

an implantable signal delivery device positionable proximate a target neural population in a patient; and

a signal generator having a controller programmed with instructions that, when executed, cause the signal generator to:

deliver a first paresthesia-free electrical signal to the target neural population via the implanted signal delivery device for a first stimulation period and according to a first stimulation schedule in which the first paresthesia-free electrical signal is delivered for at least 12 hours per day, wherein the first paresthesia-free electrical signal at least partially alleviates one or more patient symptoms; and

after the first stimulation period, automatically deliver a second paresthesia-free electrical signal to the target neural population via the implanted signal delivery device for a second stimulation period and according to a second stimulation schedule in which the second paresthesia-free electrical signal is delivered for less than 6 hours per day, wherein the second paresthesia-free electrical signal at least partially maintains the alleviation of the one or more patient symptoms achieved during the first stimulation period.

73 - 84 . (canceled)

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →